Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm
about
Depletion of nuclear histone H2A variants is associated with chronic DNA damage signaling upon drug-evoked senescence of human somatic cellsApplication of proteomics to cerebrovascular disease.Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis.Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues.Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflowPredicting the outcomes for out-of-hospital cardiac arrest patients using multiple biomarkers and suspension microarray assaysA Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression - A Pilot Study.Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumApolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.Blood microRNAs as potential diagnostic markers for hemorrhagic stroke.The role of apolipoprotein E in neurodegeneration and cardiovascular disease.Peripheral biomarkers of stroke: Focus on circulatory microRNAsBlood-based protein biomarkers for stroke differentiation: A systematic review.Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics.
P2860
Q24305743-92D40F18-B97C-49E9-92CB-E7F2DF7562ADQ34312457-CF72FD56-7ED2-48A3-8F28-97BA85826A64Q34392988-B75E4C6F-CA92-4EFF-BCC3-552834FA1343Q36745621-B8A7A05D-4E3D-4795-BD37-596493865FAEQ36889587-551E9888-32B3-4E53-BD26-EF99ED63939BQ36964921-E4EC0C4C-474C-4E19-A9D9-A0DA90F2BA42Q37002007-FF97F8B2-253A-4EE5-94DE-477EF6E77CA3Q37187946-3B3D0648-108F-4353-BCBE-798ACB185014Q37391305-13120158-55AA-492D-8242-7208AAA06C80Q37655630-A22EACE0-7B2D-4CF1-945C-4204E6AEBF0CQ38206263-C699DB33-2970-4081-BB72-7618C0761EB0Q38922418-DAC27888-CAC1-4535-BD40-B7766A18D38FQ39269033-14FDBAD5-BB7F-4AF1-8722-EF43AB285785Q47159530-7F26F30A-9974-4A73-9C56-BCFF9473E3DD
P2860
Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Discrimination of ischemic and ...... to multi-marker ROC algorithm
@en
Discrimination of ischemic and ...... to multi-marker ROC algorithm.
@nl
type
label
Discrimination of ischemic and ...... to multi-marker ROC algorithm
@en
Discrimination of ischemic and ...... to multi-marker ROC algorithm.
@nl
prefLabel
Discrimination of ischemic and ...... to multi-marker ROC algorithm
@en
Discrimination of ischemic and ...... to multi-marker ROC algorithm.
@nl
P2093
P2860
P356
P1476
Discrimination of ischemic and ...... to multi-marker ROC algorithm
@en
P2093
Amol Prakash
Bryan Krastins
David A Sarracino
Ferdinand Buonanno
Jennifer N Sutton
Mary F Lopez
Michael Athanas
MingMing Ning
Oksana Gvozdyak
P2860
P304
P356
10.1002/PRCA.201100041
P577
2012-04-01T00:00:00Z